Cáncer de mama precoz: el caso de la neoadyuvancia en HER2 positivo - page 11

Efficacy of neoadjuvant

trastuzumab in patients with HER-2

positive breast cancer: the

NOAH

(

djuvant

erceptin) Phase III

trial

Gianni, et al. Lancet 2010

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,2,3,4,5,6,7,8,9,10 12,13,14,15,16,17,18,19,20,21,...47